W Bradford Smith's Net Worth
$1.23 Million
Who is W Bradford Smith?
W Bradford Smith has an estimated net worth of $1.23 Million. This is based on reported shares across multiple companies, which include OCULAR THERAPEUTIX, INC, NeuroMetrix, Inc., Lyra Therapeutics, Inc., and Homology Medicines, Inc..
SEC CIK
W Bradford Smith's CIK is 0001317678
Past Insider Trading and Trends
2019 was W Bradford Smith's most active year for acquiring shares with 8 total transactions. W Bradford Smith's most active month to acquire stocks was the month of January. 2019 was W Bradford Smith's most active year for disposing of shares, totalling 15 transactions. W Bradford Smith's most active month to dispose stocks was the month of December. 2021 saw W Bradford Smith paying a total of $8,640.00 for 162,750 shares, this is the most they've acquired in one year. In 2020 W Bradford Smith cashed out on 36,000 shares for a total of $316,850.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OCULAR THERAPEUTIX, INC (OCUL) Snapshot price: $5.04
CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeuroMetrix, Inc. (NURO) Snapshot price: $3.1
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) Snapshot price: $0.7151
See remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -20.78% | -3.73K |
$1.39 | -$5,187.78 | 14.22K |
Scheduled
|
Jan 9
| ||
Form 4
| +306.25% | 13.53K |
—
|
—
| 17.95K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
∞
| 4.42K |
$3.78 | -$8,248.40 | 4.42K |
Scheduled
|
Jan 1 - Jan 5
| ||
Form 4
|
—
|
0
|
$7.45 | -$183,784.95 |
0
|
Scheduled
|
Feb 5 - Feb 8
| ||
Form 4
|
—
|
0
|
$8.40 | -$186,286.80 |
0
|
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$10.57 | -$119,194.80 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
$8.38 | -$185,586.00 |
0
|
Scheduled
|
Nov 29 - Dec 2
| ||
Form 4
|
—
|
0
|
$9.02 | -$100,526.77 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$9.69 | -$108,579.00 |
0
|
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$9.01 | -$100,350.60 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$9.82 | -$110,131.20 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$10.29 | -$115,824.00 |
0
|
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||